651
To describe a probable interaction between enteral feeds and levodopa leading to neuroleptic malignant-like syndrome (NMLS) in a polytrauma patient with Parkinson's disease (PD).
 a polytrauma patient with Parkinson's disease (PD): Subject; polytrauma: Subject.Disorder; neuroleptic malignant-like syndrome (NMLS): Effect; interaction between enteral feeds and levodopa: Treatment; levodopa: Treatment.Drug; enteral feeds: Treatment.Drug; Parkinson's disease (PD): Treatment.Disorder; enteral feeds: Combination.Drug; levodopa: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 a polytrauma patient with Parkinson's disease (PD): Subject; polytrauma: Subject.Disorder; neuroleptic malignant-like syndrome (NMLS): Effect; interaction between enteral feeds and levodopa: Treatment; levodopa: Treatment.Drug; enteral feeds: Treatment.Drug; Parkinson's disease (PD): Treatment.Disorder; enteral feeds: Combination.Drug; levodopa: Combination.Drug